Effectiveness of high-dose ICS/LABA combination in adults
with uncontrolled asthma on medium-dose ICS/LABA
12-WEEK NON-INTERVENTIONAL OBSERVATIONAL STUDY
We invite you to participate in a single-center observational study entitled "Effectiveness of high-dose ICS/LABA combination in adults with uncontrolled asthma on medium-dose ICS/LABA", which aims to assess the effectiveness of using high-dose ICS in combination with LABA in patients with chronic bronchial asthma who do not achieve disease control despite using medium-dose ICS/LABA.
The obtained results will be a step towards evaluating the therapy of high-dose ICS/LABA combinations and will provide reliable data for further analysis.
To start the study, it is necessary to conclude an online agreement, so please register and follow the instructions that appear on the computer screen. After successful registration and signing of the electronic agreement, please log in with the data obtained during the account creation process.
BioStat® oversees the smooth course of the study and data analysis.
In case of any questions, please contact the study organizer:
BioStat Sp. z o.o.
ul. Kowalczyka 17, 44-206 Rybnik
tel: +48 666 069 814
email: [email protected]
Please fill out the registration form and sign the agreement to start the study.
Please log in with the data received after signing the online agreement.
Project sponsored by: